Pharmacokinetics and Safety of the 100 Mcg Misoprostol Vaginal Insert (MVI 100)
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will provide pharmacokinetic data for the MVI 100 (100 mcg) misoprostol vaginal
insert when administered to nulliparous women at term gestation requiring cervical ripening
and induction of labor.